Our company specializes in 3D pathology imaging, providing physicians and researchers with comprehensive pathological data and AI-assisted interpretation. We developed Metalite, the world’s first 3D pathology analysis software equipped with an AI module, enabling detailed assessment of tissue morphology variations and tumor target molecule distribution to enhance cancer diagnosis and drug development accuracy. We also offer customized tissue processing and antibody staining services for various solid tumors, including breast, lung, and colorectal cancers. Using IVD-grade antibodies such as Her2, EGFR, PD-L1, and CD markers, our platform supports 3D tumor region mapping, feature interpretation, and antibody expression curve analysis, delivering deeper and more integrated pathological insights for clinical and research applications.